{"id":"bpan-patients","safety":{"commonSideEffects":[{"rate":null,"effect":"Unknown"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"BPAN Patients is being investigated for its potential to treat a rare genetic disorder. The exact mechanism of action is not well understood, but it is thought to target the underlying genetic cause of the disorder.","oneSentence":"BPAN Patients is a treatment for a rare genetic disorder.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T03:57:22.753Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Treatment of BPAN (Beta-Propeller Protein-Associated Neurodegeneration)"}]},"trialDetails":[{"nctId":"NCT05954494","phase":"","title":"Protection Response to Cellular Stress in BPAN's Patient Study","status":"COMPLETED","sponsor":"Hospices Civils de Lyon","startDate":"2023-10-23","conditions":"Children and Adults With BPAN Carrying Pathogenic Variants of WDR45","enrollment":21},{"nctId":"NCT05522374","phase":"","title":"TIRCON International NBIA Registry","status":"RECRUITING","sponsor":"LMU Klinikum","startDate":"2012-06-14","conditions":"Neurodegeneration With Brain Iron Accumulation (NBIA), Pantothenate Kinase-associated Neurodegeneration (PKAN), Beta-Propeller Protein-Associated Neurodegeneration (BPAN)","enrollment":2000},{"nctId":"NCT02587858","phase":"","title":"NBIAready: Online Collection of Natural History Patient-reported Outcome Measures","status":"UNKNOWN","sponsor":"Susan J. Hayflick","startDate":"2015-04","conditions":"Neurodegeneration With Brain Iron Accumulation (NBIA)","enrollment":300}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":8,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_2","status":"active","brandName":"BPAN Patients","genericName":"BPAN Patients","companyName":"Hospices Civils de Lyon","companyId":"hospices-civils-de-lyon","modality":"Biologic","firstApprovalDate":"","aiSummary":"BPAN Patients is a treatment for a rare genetic disorder. Used for Treatment of BPAN (Beta-Propeller Protein-Associated Neurodegeneration).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}